Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. It focuses on innovative technology platforms such as novel adjuvant, protein engineering, and immunological evaluation platforms. The company was founded by Yong Liu on May 18, 2012 and is headquartered in Taizhou City, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company